Lebeau O, Van Delden C, Garbino J, Robert J, Lamoth F, Passweg J, Chalandon Y
Department of Medicine, Hematology Division, University Hospital Geneva, Geneva, Switzerland.
Transpl Infect Dis. 2010 Jun;12(3):269-72. doi: 10.1111/j.1399-3062.2009.00484.x. Epub 2010 Feb 16.
Invasive Zygomycetes infection complicating prolonged neutropenia is associated with high mortality in the absence of immune recovery. We report a patient who developed disseminated zygomycosis due to Rhizopus microsporus during induction chemotherapy for acute myeloid leukemia. Rescue allogeneic hematopoietic stem cell transplantation (allo-HSCT) was performed as her only chance of cure of this infection and to treat refractory leukemia. Posaconazole combined with liposomal amphotericin B contained the zygomycosis during prolonged neutropenia due to allo-HSCT followed by intense immunosuppression for grade IV acute graft-versus-host disease. Surgical removal of all infected sites after immune recovery, with prolonged posaconazole treatment, ultimately cured the infection. New combination antifungal therapies might sufficiently control disseminated zygomycosis to allow allo-HSCT to be performed, assuring life-saving immune recovery. Surgery appears to be necessary for definite cure of these infections.
侵袭性接合菌感染并发长期中性粒细胞减少症,在免疫功能未恢复的情况下死亡率很高。我们报告了一名在急性髓系白血病诱导化疗期间因微小根霉发生播散性接合菌病的患者。进行挽救性异基因造血干细胞移植(allo-HSCT)是治愈这种感染以及治疗难治性白血病的唯一机会。泊沙康唑联合脂质体两性霉素B在allo-HSCT导致的长期中性粒细胞减少期间控制了接合菌病,随后因IV级急性移植物抗宿主病进行了强化免疫抑制。免疫恢复后手术切除所有感染部位,并长期使用泊沙康唑治疗,最终治愈了感染。新的联合抗真菌疗法可能足以控制播散性接合菌病,从而能够进行allo-HSCT,确保挽救生命的免疫恢复。手术似乎是彻底治愈这些感染所必需的。